Site 160: Forbes Norris MDA/ALS Research and Treatment Center — San Francisco, California

Site 160: Forbes Norris MDA/ALS Research and Treatment Center is a clinical research site located in San Francisco, California, United States 94115.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site 160: Forbes Norris MDA/ALS Research and Treatment Center has participated in 1 clinical trials.

Therapeutic areas: Myasthenia Gravis, Generalized.

Sponsors: Ra Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 160: Forbes Norris MDA/ALS Research and Treatment Center?

Site 160: Forbes Norris MDA/ALS Research and Treatment Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 160: Forbes Norris MDA/ALS Research and Treatment Center conducted?

Site 160: Forbes Norris MDA/ALS Research and Treatment Center has 1 clinical trials on record. Their work covers Myasthenia Gravis, Generalized.

Is Site 160: Forbes Norris MDA/ALS Research and Treatment Center accredited by Crixeo Health?

Site 160: Forbes Norris MDA/ALS Research and Treatment Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 160: Forbes Norris MDA/ALS Research and Treatment Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.